Page last updated: 2024-08-22

vidarabine and Kidney Neoplasms

vidarabine has been researched along with Kidney Neoplasms in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (7.14)18.2507
2000's11 (78.57)29.6817
2010's2 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ando, T; Kamachi, K; Kimura, S; Kojima, K; Nishijima, A; Takeshita, M1
Barkholt, L; Ericzon, BG; Mattsson, J; Omazic, B; Potácová, Z; Remberger, M; Ringdén, O; Söderdahl, G; Wersäll, P1
Baron, F; Baudoux, E; Beguin, Y; Bonnet, C; Fillet, G; Frère, P; Gothot, A; Hafraoui, K; Herens, C; Seidel, L; Vanbellinghen, JF; Vanstraelen, G; Wanten, N; Willems, E1
Amato, R; Butler, EB; Furge, K; Gao, Y; Hui, Z; Li, Y; Mai, W; Qian, CN; Teh, BS; Teh, BT; Tretiakova, M; Wang, X; Zhang, Z; Zhu, JX1
Abonour, R; Logan, TF; Nelson, RP1
Albiin, N; Barkholt, L; Hentschke, P; Martola, J; Mattsson, J; Pisa, P; Remberger, M; Ringdén, O; Söderberg, M; Thörne, A; Uzunel, M; Wernerson, A; Wersäll, P1
Koshida, K; Nakao, S; Namiki, M; Takami, A1
Fujioka, T; Ishida, Y; Numaoka, H; Omori, S; Ono, Y1
Childs, RW; Leppert, MF; Otterud, BE; Riddell, SR; Sandmaier, BM; Storb, R; Thompson, JA; Tykodi, SS; Warren, EH1
Langiewicz, P; Rzepecki, P; Sarosiek, T; Szczylik, C; Zolnierek, J1
Nelson, JA; Pan, BF1
Bertetto, O; Busca, A; de Fabritiis, P; Falda, M; Locatelli, F; Novarino, A; Picardi, A; Zeuli, M1
Barrett, J; Childs, RW; Clave, E; Hensel, N; Plante, M; Tisdale, J1
Da Prada, GA; Della Cuna, GR; Giorgiani, G; Giraldi, E; Landonio, G; Locatelli, F; Pedrazzoli, P; Schiavo, R; Siena, S; Zambelli, A1

Reviews

2 review(s) available for vidarabine and Kidney Neoplasms

ArticleYear
Nonablative hematopoietic cell transplantation for the treatment of metastatic renal cell carcinoma.
    Bone marrow transplantation, 2002, Volume: 30, Issue:12

    Topics: Antineoplastic Agents; Carcinoma, Renal Cell; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Cytokines; Graft Survival; Graft vs Host Disease; Graft vs Tumor Effect; Humans; Immunotherapy, Adoptive; Kidney Neoplasms; Melphalan; Multicenter Studies as Topic; Nephrectomy; Peripheral Blood Stem Cell Transplantation; Recombinant Proteins; Survival Analysis; Thiotepa; Transplantation Chimera; Transplantation Conditioning; Treatment Outcome; Vidarabine

2002
[Nonmyeloablative allogeneic peripheral blood stem cell transplantation of renal cell carcinoma].
    Nihon rinsho. Japanese journal of clinical medicine, 2003, Volume: 61, Issue:9

    Topics: Aged; Carcinoma, Renal Cell; Cyclophosphamide; Female; Graft vs Host Disease; Graft vs Tumor Effect; Humans; Kidney Neoplasms; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Prognosis; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous; Vidarabine

2003

Trials

3 trial(s) available for vidarabine and Kidney Neoplasms

ArticleYear
Non-myeloablative transplantation with CD8-depleted or unmanipulated peripheral blood stem cells: a phase II randomized trial.
    Leukemia, 2009, Volume: 23, Issue:3

    Topics: Adult; Aged; Carcinoma, Renal Cell; CD8-Positive T-Lymphocytes; Disease-Free Survival; Female; Follow-Up Studies; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Kidney Neoplasms; Lymphocyte Depletion; Male; Middle Aged; Myelodysplastic Syndromes; Myeloproliferative Disorders; Peripheral Blood Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation

2009
Allogeneic hematopoietic cell transplantation for metastatic renal cell carcinoma after nonmyeloablative conditioning: toxicity, clinical response, and immunological response to minor histocompatibility antigens.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Dec-01, Volume: 10, Issue:23

    Topics: Adenocarcinoma, Clear Cell; Adult; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Papillary; Carcinoma, Renal Cell; Cells, Cultured; Cyclosporine; Female; Graft vs Host Disease; Graft vs Tumor Effect; Hematopoietic Stem Cell Transplantation; Humans; Kidney Neoplasms; Male; Middle Aged; Minor Histocompatibility Antigens; Mycophenolic Acid; Myeloid Cells; T-Lymphocytes, Cytotoxic; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation

2004
Allogeneic non-myeloablative hematopoietic stem cell transplantation for treatment of metastatic renal cell carcinoma -- single center experience.
    Neoplasma, 2005, Volume: 52, Issue:3

    Topics: Adult; Bone Neoplasms; Brain Neoplasms; Carcinoma, Renal Cell; Cyclophosphamide; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Transplantation Conditioning; Vidarabine

2005

Other Studies

9 other study(ies) available for vidarabine and Kidney Neoplasms

ArticleYear
Small lymphocytic lymphoma presenting as bulky renal incidentaloma.
    International journal of hematology, 2014, Volume: 100, Issue:2

    Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Cyclophosphamide; Humans; Kidney; Kidney Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell; Magnetic Resonance Imaging; Male; Middle Aged; Rituximab; Tomography, X-Ray Computed; Vidarabine

2014
Long-Term Follow-Up of Allogeneic Hematopoietic Stem Cell Transplantation for Solid Cancer.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2016, Volume: 22, Issue:4

    Topics: Adenocarcinoma; Adult; Aged; Bile Duct Neoplasms; Breast Neoplasms; Colonic Neoplasms; Cyclophosphamide; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Kidney Neoplasms; Male; Middle Aged; Myeloablative Agonists; Neoplasm Metastasis; Pancreatic Neoplasms; Prostatic Neoplasms; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous; Vidarabine

2016
Radiosensitization by inhibiting STAT1 in renal cell carcinoma.
    International journal of radiation oncology, biology, physics, 2009, Jan-01, Volume: 73, Issue:1

    Topics: Antineoplastic Agents; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Survival; Humans; Kidney Neoplasms; Radiation-Sensitizing Agents; STAT1 Transcription Factor; Vidarabine

2009
Low-intensity conditioning and hematopoietic stem cell transplantation in patients with renal and colon carcinoma.
    Bone marrow transplantation, 2003, Volume: 31, Issue:4

    Topics: Adenocarcinoma; Aged; Breast Neoplasms; Cholangiocarcinoma; Colonic Neoplasms; Female; Follow-Up Studies; Humans; Kidney Neoplasms; Male; Middle Aged; Retrospective Studies; Stem Cell Transplantation; Survival Analysis; Time Factors; Transplantation Conditioning; Treatment Outcome; Vidarabine; Whole-Body Irradiation

2003
[Reduced intensity stem cell transplantation for metastatic renal cell carcinoma].
    Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 2004, Volume: 95, Issue:3

    Topics: Adult; Busulfan; Carcinoma, Renal Cell; Cyclosporine; Fatal Outcome; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Kidney Neoplasms; Lung Neoplasms; Male; Methotrexate; Middle Aged; Salvage Therapy; Stem Cell Transplantation; Transplantation Chimera; Transplantation Conditioning; Vidarabine

2004
Dihydrodiol dehydrogenase in drug resistance and sensitivity of human carcinomas.
    Cancer chemotherapy and pharmacology, 2007, Volume: 59, Issue:5

    Topics: Antineoplastic Agents; Carcinoma, Renal Cell; Caspase 3; Cell Line, Tumor; Cladribine; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Enzyme Activation; Humans; Kidney Neoplasms; Oxidoreductases; Transfection; Vidarabine

2007
Nonmyeloablative allogeneic blood stem cell transplantation in patients with metastatic solid tumors.
    Hematology (Amsterdam, Netherlands), 2006, Volume: 11, Issue:3

    Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Renal Cell; Colonic Neoplasms; Feasibility Studies; Female; Graft Survival; Graft vs Host Disease; Graft vs Tumor Effect; Humans; Immunosuppressive Agents; Kidney Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Peripheral Blood Stem Cell Transplantation; Postoperative Complications; Rectal Neoplasms; Sarcoma; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation

2006
Successful treatment of metastatic renal cell carcinoma with a nonmyeloablative allogeneic peripheral-blood progenitor-cell transplant: evidence for a graft-versus-tumor effect.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1999, Volume: 17, Issue:7

    Topics: Antineoplastic Agents; Carcinoma, Renal Cell; Cyclophosphamide; Graft vs Tumor Effect; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Kidney Neoplasms; Lung Neoplasms; Male; Middle Aged; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine

1999
Allogeneic blood stem cell transplantation after a reduced-intensity, preparative regimen: a pilot study in patients with refractory malignancies.
    Cancer, 2002, May-01, Volume: 94, Issue:9

    Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Breast Neoplasms; Carcinoma, Renal Cell; Child; Cyclophosphamide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Kidney Neoplasms; Male; Melanoma; Middle Aged; Neoplasms; Pilot Projects; Sarcoma; Survival Rate; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine

2002